- Home
- KTTA vs IBG Comparison
KTTA vs IBG Comparison
Compare KTTA & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- IBG
- Stock Information
- Founded
- KTTA 2020
- IBG 2018
- Country
- KTTA United States
- IBG Australia
- Employees
- KTTA N/A
- IBG N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- KTTA Health Care
- IBG Consumer Staples
- Exchange
- KTTA Nasdaq
- IBG Nasdaq
- Market Cap
- KTTA 5.1M
- IBG 5.4M
- IPO Year
- KTTA 2021
- IBG 2024
- Fundamental
- Price
- KTTA $0.68
- IBG $0.73
- Analyst Decision
- KTTA
- IBG Strong Buy
- Analyst Count
- KTTA 0
- IBG 1
- Target Price
- KTTA N/A
- IBG N/A
- AVG Volume (30 Days)
- KTTA 119.6K
- IBG 6.2M
- Earning Date
- KTTA 08-19-2025
- IBG 08-19-2025
- Dividend Yield
- KTTA N/A
- IBG N/A
- EPS Growth
- KTTA N/A
- IBG N/A
- EPS
- KTTA N/A
- IBG N/A
- Revenue
- KTTA N/A
- IBG $2,931,243.00
- Revenue This Year
- KTTA N/A
- IBG N/A
- Revenue Next Year
- KTTA N/A
- IBG N/A
- P/E Ratio
- KTTA N/A
- IBG N/A
- Revenue Growth
- KTTA N/A
- IBG N/A
- 52 Week Low
- KTTA $0.65
- IBG $0.44
- 52 Week High
- KTTA $7.50
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- KTTA 38.79
- IBG N/A
- Support Level
- KTTA $0.67
- IBG N/A
- Resistance Level
- KTTA $0.79
- IBG N/A
- Average True Range (ATR)
- KTTA 0.04
- IBG 0.00
- MACD
- KTTA 0.00
- IBG 0.00
- Stochastic Oscillator
- KTTA 23.70
- IBG 0.00
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.